Our Company
Johnson & Johnson to Participate in the 39th Annual J.P. Morgan Healthcare Conference
Johnson & Johnson to Participate in the 39th Annual J.P. Morgan Healthcare Conference

New Brunswick, NJ (December 14, 2020) -- Johnson & Johnson (NYSE: JNJ) will participate virtually in the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11th. Alex Gorsky, Chairman and Chief Executive Officer and Joseph J. Wolk, Executive Vice President and Chief Financial Officer will represent the Company in a session scheduled at 2:00 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 24-hrs after the live webcast.

  • Press Contact:
    Courtney Dugan
    cdugan1@its.jnj.com
    (347) 452-1061 (M)

    Investor Contacts:
    Christopher DelOrefice
    (732) 524-2955

    Lisa Romanko
    (732) 524-2034

    Sarah Wood
    (732) 524-2617
This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue